XML 30 R14.htm IDEA: XBRL DOCUMENT v3.26.1
Balance Sheet Components
3 Months Ended
Mar. 31, 2026
Balance Sheet Components  
Balance Sheet Components

8. Balance Sheet Components (in thousands)

March 31, 

December 31, 

  ​ ​ ​

2026

  ​ ​ ​

2025

  ​ ​ ​

Prepaid and Other Current Assets

Interest receivable

$

1,155

$

337

Prepaid research and development manufacturing expenses

1,564

599

Prepaid facility expenses

34

35

Prepaid insurance

69

138

Other

 

367

 

318

$

3,189

$

1,427

Property and Equipment

Laboratory equipment

$

2,713

$

2,646

Computer equipment and purchased software

 

190

 

190

Leasehold improvements

 

33

 

33

Construction in progress

23

 

2,959

 

2,869

Less: accumulated depreciation and amortization

 

(2,677)

 

(2,649)

$

282

$

220

Accrued and Other Liabilities

Accrued clinical trial expense

$

3,300

$

3,566

Accrued manufacturing expense

 

1,794

 

1,812

Personnel related

 

1,381

 

641

Accrued legal and accounting

304

229

Other

 

206

 

238

$

6,985

$

6,486

During the three months ended March 31, 2026 and 2025, the Company recorded approximately $29,000 and $22,000 in depreciation expense, respectively.